Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The clearance of heterologous protein from the circulation of normal and immunized man.

Literature DB >> 13575530

The clearance of heterologous protein from the circulation of normal and immunized man.

A P FLETCHER, N ALKJAERSIG, S SHERRY.

Abstract

Entities: Species

Keywords: PROTEINS/metabolism; STREPTODORNASE AND STREPTOKINASE/in blood

Mesh：

Substances：

Year: 1958 PMID： 13575530 PMCID： PMC1062800 DOI： 10.1172/JCI103719

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

19 in total

1. The use of radioactive isotopes in immunological investigations. X. The fate of some intravenously injected native proteins in normal and immune rabbits.

Authors: G E FRANCIS; J D HAWKINS; A WORMALL
Journal: Biochem J Date: 1957-03 Impact factor: 3.857

2. Effects in patients of intravenous infusions of purified streptokinase preparations.

Authors: A J JOHNSON; A P FLETCHER; W R MCCARTY; W S TILLETT
Journal: Proc Soc Exp Biol Med Date: 1957-02

3. Methods employed for purification of streptokinase.

Authors: A P FLETCHER; A J JOHNSON
Journal: Proc Soc Exp Biol Med Date: 1957-01

4. An approach to intravascular fibrinolysis in man.

Authors: S SHERRY; A P FLETCHER; N ALKAJERSIG; F E SMYRNIOTIS
Journal: Trans Assoc Am Physicians Date: 1957

5. Comparative studies on the turnover of serum albumin in normal human subjects.

Authors: S MARGEN; H TARVER
Journal: J Clin Invest Date: 1956-10 Impact factor: 14.808

6. Distribution and elimination of 131 I- and 14C-labelled plasma proteins in the rabbit.

Authors: S COHEN; R C HOLLOWAY; C MATTHEWS; A S MCFARLANE
Journal: Biochem J Date: 1956-01 Impact factor: 3.857

7. Labelling of plasma proteins with radioactive iodine.

Authors: A S MCFARLANE
Journal: Biochem J Date: 1956-01 Impact factor: 3.857

8. The in vivo stability of the I131 protein label of rabbit antibody in guinea pigs as determined by the quantitative precipitin reaction.

Authors: L R MELCHER; S P MASOUREDIS
Journal: J Immunol Date: 1951-11 Impact factor: 5.422

9. Antigen elimination from the blood as an early manifestation of the immune response.

Authors: D W TALMAGE; F J DIXON; S C BUKANTZ; G J DAMMIN
Journal: J Immunol Date: 1951-10 Impact factor: 5.422

10. The turnover rate of serum albumin in man as measured by I131-tagged albumin.

Authors: K STERLING
Journal: J Clin Invest Date: 1951-11 Impact factor: 14.808

14 in total

1. ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors: A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal: J Clin Invest Date: 1964-04 Impact factor: 14.808

2. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors: A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal: J Clin Invest Date: 1962-04 Impact factor: 14.808

7. Consequences of antibody binding in vitro on the pharmacological properties of anisoylated plasminogen streptokinase activator complex.

Authors: R Fears; H Ferres; M Hibbs; R Standring
Journal: Drugs Date: 1987 Impact factor: 9.546

8. [The technique of quantitative determination of streptokinase in the patient's plasma (author's transl)].

Authors: H Auel; M Martin
Journal: Klin Wochenschr Date: 1975-09-01

Review 9. Antithrombotic drugs: part II.

Authors: A S Gallus; J Hirsh
Journal: Drugs Date: 1976 Impact factor: 9.546

Review 10. Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors: D M Lutomski; M Bottorff; K Sangha
Journal: Clin Pharmacokinet Date: 1995-01 Impact factor: 6.447